Amidst COVID-19, Disease X looms and more cross-cutting R&D funds needed for all emerging infectious diseases, says new G-FINDER report (17 September 2020)
COVID-19 vaccine candidates report promising results from early and mid-stage clinical trials, but may lack real-world applicability (10 September 2020)
New G-FINDER Snapshot series debuts on World Mosquito Day looking at R&D funding and new tools to fight the world’s deadliest animal (20 August 2020)
New G-FINDER report on sexual and reproductive health R&D finds new products, investments and funders required for many needs (13 August 2020)
Huge, rapid R&D scale-up to fight COVID-19 unmatched, but most new tools remain months away or longer (25 June 2020)
Funding for neglected disease research hits record high, increases for third straight year (30 January 2020)
Science: Advancing new tools for infectious diseases (November 2020)
MSN News: Human rights ‘pushed to the curb’ in the world’s rush to a Covid-19 vaccine (29 October 2020)
Business Day (South Africa): Human Rights Watch supports SA’s call to scrap Covid-19 patents (29 October 2020)
Research Professional News: The time to start planning for the next pandemic is now (15 October 2020)
The Hill: Protecting the profits of a few could prevent vaccine access for all (14 October 2020)
India Today: Chasing the cure (10 October 2020)
Politico: Ranking countries’ likelihood of securing a coronavirus vaccine (25 September 2020)
Research Professional News: Infectious disease funding ‘follows the headlines’ (21 September 2020)
SciDevNet: Keep focus on emerging infections, Disease X: analysts (17 September 2020)
KFF.org: Policy Cures Research’s G-FINDER 2020 Report Tracks Global Funding On Emerging Infectious Diseases R&D (17 September 2020)
STAT Morning Rounds: R&D funding for infectious diseases rises fourfold since 2014 (17 September 2020)
Becker’s Hospital Review: US infectious disease funding up fourfold since 2014, report finds (17 September 2020)
The Telegraph (UK): Why China could be poised to win the race for a coronavirus vaccine (12 September 2020)
Politico: Still wanted: a treatment for the coronavirus (11 September 2020)
Down to Earth: Will there be a middle path for affordable COVID-19 vaccines (8 September 2020)
The Seattle Times: The Gates Foundation, a global health behemoth, aims its massive bank account and disease-fighting expertise at COVID-19 (6 September 2020)
CFR.org: What Is the World Doing to Create a COVID-19 Vaccine? (26 August 2020)
Health Policy Watch: Most Sexual & Reproductive Health Research Financing Comes From 3 Major Donors – And COVID-19 Could Further Shrink Funding (13 August 2020)
The New Republic: Can Platform Vaccines Really Save Us? (10 August 2020)
Politico: Europe has yet to live up to its Covid-19 promises (also on Yahoo News) (7 August 2020)
Axios Science: CRISPR’s COVID push — Deforestation’s irreversible damage — Brightest fluorescent material (6 August 2020)
Le Parisien: Vaccin contre le Covid-19 : priorité aux soignants, aux personnes âgées et à risque (28 July 2020)
Le Monde: Calendrier, essais cliniques, financements: où en est-on de la course au vaccin contre le Covid-19? (27 June 2020)
Mediapart.fr: Vaccin contre le Covid-19: la toute-puissance de l’industrie pharmaceutique (22 July 2020)
LiveMint: The unprecedented race for the covid-19 vaccine, in five charts (13 July 2020)
Financial Times: Health (1 July 2020)
Research Professional News: Covid-19 R&D tops $8bn as WHO calls for new funds (29 June 2020)
The Telegraph (UK): More than $8.5bn committed to finding drugs and vaccines to fight coronavirus (26 June 2020)
Research Professional News: Covid-19 R&D: the global funding picture (19 June 2020)
STAT: First Opinion: Covid-19 has exposed the limits of the pharmaceutical market model (19 May 2020)
The Wall Street Journal: Bill Gates has regrets (11 May 2020)
Bhekisisa: Will South Africa maintain its role as top funder of health research and development? (18 March 2020)
Brookings: Preparing for pandemics such as coronavirus—will we ever break the vicious cycle of panic and neglect? (11 February 2020)
STAT: First Opinion: What record-high funding for neglected diseases doesn’t tell us about R&D for them (4 February 2020)
Forbes: Record Funding For Global Health Research, But Neglected Tropical Diseases Remain Neglected (29 January 2020)
Policy Cures Research is a global health think tank with a long and pioneering history in global health R&D data collection and analysis, securing our position as a trusted source of quality evidence within the sector. More about us